SCHEMBL23917530

SCHEMBL23917530

CC1Cc2ccccc2N(C(=O)/C=C/N2CCOCC2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.44
MAPT P10636 8/20 0.44
NPC1 O15118 8/20 0.44
RAB9A P51151 8/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
USP2 O75604 3/20 0.44
TP53 P04637 2/20 0.44
POLB P06746 4/20 0.41
HPGD P15428 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALOX12 P18054 2/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NOTUM Q6P988 1/20 0.40
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917206 0.90 NOTUM (0.43) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL23917198 0.77 NOTUM (0.48) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL21172497 0.73 NOTUM (0.61) SMN1; SMN2NOTUM
SCHEMBL21172644 0.73 NOTUM (0.61) SMN1; SMN2NOTUM
SCHEMBL26517034 0.72 NOTUM (0.51) ALDH1A1SMN1; SMN2NOTUMTSHR
SCHEMBL23917466 0.70 NOTUM (0.49) ALDH1A1NPC1SMN1; SMN2TP53POLB
SCHEMBL21172618 0.70 NOTUM (0.49) ALDH1A1NPC1SMN1; SMN2TP53POLB
SCHEMBL26517033 0.70 NOTUM (0.49) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL28445544 0.69 NOTUM (0.60) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL16385108 0.68 NOTUM (0.47) SMN1; SMN2MAPK1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB ALDH1A1 4290/4885MAPT 4717/4885NPC1 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.